Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study evaluating cellular mechanisms without clinical human participants
PubMed 20676404 · doi:10.1371/journal.pone.0011820
What was done
The authors investigated the mechanism of amyloid-beta (Abeta) toxicity in native brain neuronal membranes. They evaluated whether Abeta acts analogously to pore-forming toxins by measuring changes in membrane conductance, intracellular calcium influx, and ethidium bromide influx. They additionally tested whether peptides known to block Abeta neurotoxicity could alter or inhibit this membrane-perforating activity.
What was found
The abstract reports no numerical values, concentrations, or statistical metrics. Qualitatively, Abeta induced perforation of native neuronal membranes, marked by increased membrane conductance, intracellular calcium elevation, and ethidium bromide influx. Peptides that inhibit Abeta neurotoxicity slowed or prevented this membrane perforation.
Why it matters
This study suggests that Abeta synaptotoxicity occurs via direct lipid membrane pore formation rather than through specific receptor proteins, highlighting membrane perforation as a possible target for Alzheimer's disease drug screening.
Limits
This is a preclinical in vitro mechanistic study without in vivo or clinical human data. The abstract lacks specific quantitative measurements, sample sizes, exact peptide identifiers, and statistical confidence intervals.
Cited by
- supports Amyloid aggregate exposure to cell membranes induces ion transportation such as calcium influx into neurons.